Member Info for Mistral77

Auctions on the London Stock Exchange's Alternative Investment Market (AIM) are structured, timed periods (typically 7:50-8:00, 16:30-16:35, and intra-day) designed to set official opening/closing prices and boost liquidity for small-cap stocks by aggregating orders. These processes help manage high volatility and ensure fair pricing.

"Was reported as OTC" likely means a security or derivative was traded directly between two parties instead of on a public exchange, and this transaction was then reported to a regulatory body. This typically applies to securities of smaller companies, customized financial derivatives, or large institutional trades where parties want to avoid market impact.

If you look at the Avact RNS 02/09/20, you will see that Abingdon have also been contracted to manufacture the (much anticiped) Avacta antigen LFT.

We use HALO at work but the spit still has to go to a lab with it.

Great Work Hants and PL, as always.

Sounds like Medusa will only be able to sell 1 test at a time as the UK Gov et al will be hoovering up the rest.

I think Sir Al’s distribution model may have grown and changed since signing up Medusa. Oh well Boohoo!

https://mobile.twitter.com/gjbrandon/status/1296537256216461313?s=19

Totally agree!

Next gen testing won’t involve PCR or LFD but it will involve SKIN and AVCT tech/bio.

PL75,
I notice, that like myself, you have an interest in both Skin and Avacta. Do you see the two companies going forward with their JV into the next gen of testing, breathaliser or something else?

I guess Avacta are being a little quieter than SKIN as they want to get the LFD and Bams going first.

I don’t wish to contaminate either respective BB’s but just broadening the conversation on their joint development activities.

Have a read through the Covid update RNS’s.

Fake news

Phone them. They are super helpful and friendly

Look back a couple of weeks ago at my post here, warning of a placing. The numbers and the back story just looked good for it. Elon musk just gave me a foul mouthed rant for mentioning it.

GDR has never really recovered from the placing. Great story there too!

Shorter,

After being steady in the 170’s the Avacta share price was pulled back just before the placing, it then dipped below the placing price the other day and is only a fraction above it now after news of the therapy. I won’t buy today in the pacing, I will get them for the same price or better in a few days

I still think that ODX are better off with the Mologic Deal than Abingdon and the RTC. In the end that will deliver the big upside.

You know this will sit 10% above placing price, until the placing at which point one will be able to buy in the high 30’s. Dyor and look at the numbers for AIM placing of other companies.

Agree Sam, over subscribed means increase the offer and further dilute.

I warned people of a potential placing two weeks ago. The numbers were lining up a treat for it. I got lambasted for my opinion by Elonbigmouththescent.

I don’t believe that is where the money will go to. They need to write off over £8m from the part of the operation that they stopped last week.

DF miles off. That is if Abingdon even tell Omega they have a DF. Looks like Abingdon are lining thIs up for themselves. If I was Abingdon and had developed the test I don’t think I would want to share the IP outside of the tiny UK gov piece.

Either sign up to open offer, easy or if you want to wrap it in ISA, call you platform company directly.

Oops

If you want it wrapped into an ISA call HL direct